Maternal serum placental growth factor and α-fetoprotein testing in first trimester screening for Down syndrome

Prenatal Diagnosis

Volumn 33, Issue 5, 2013, Pages 457-461

  Donalson, Kim ^a   Turner, Steve ^a   Morrison, Lesley ^a   Liitti, Päivi ^b   Nilsson, Christel ^b   Cuckle, Howard ^c  

^a ROYAL VICTORIA INFIRMARY   (United Kingdom)

^b Wallac Oy   (Finland)

^c Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; PLACENTAL GROWTH FACTOR; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ADULT; ARTICLE; BODY WEIGHT; CASE CONTROL STUDY; CLINICAL PROTOCOL; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN SYNDROME; FALSE POSITIVE RESULT; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; MAJOR CLINICAL STUDY; MATERNAL SERUM; PREDICTIVE VALUE; PRENATAL SCREENING; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; SMOKING;

ADULT; ALPHA-FETOPROTEINS; CASE-CONTROL STUDIES; DOWN SYNDROME; FALSE POSITIVE REACTIONS; FEMALE; GESTATIONAL AGE; HUMANS; MATERNAL AGE; PREGNANCY; PREGNANCY PROTEINS; PREGNANCY TRIMESTER, FIRST; PRENATAL DIAGNOSIS; YOUNG ADULT;

EID: 84877621524     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.4087     Document Type: Article

References (16)

1. Zaragoza E, Akolekar R, Poon LC, et al. Maternal serum placental growth factor at 11-13 weeks in chromosomally abnormal pregnancies. Ultrasound Obstet Gynecol 2009;33:382-6.
2. Cowans NJ, Stamatopoulou A, Spencer K. First trimester maternal serum placental growth factor in trisomy 21 pregnancies. Prenat Diagn 2010;30:449-53.
3. Koster MP, Wortelboer EJ, Stoutenbeek P, et al. Modeling Down Syndrome screening performance using first trimester serum markers. Ultrasound Obstet Gynecol 2011;38:134-9.
4. Pandya P, Wright D, Syngelaki A, et al. Material serum placental growth factor in prospective screening for aneuploidies at 8-13 weeks gestation. Fetal Diagn Ther 2012;31(2):87-93.
5. Kagan K, Hoopmann M, Abele H, Alkier R, Lüthgens K. First trimester combined screening for trisomy 21 with different combinations of placental growth factor, free β-hCG and PAPP-A. Ultrasound Obstet Gynecol. 2012 [Epub ahead of print]
6. Cuckle HS, Benn PA. In Multianalyte Maternal Serum Screening for Chromosomal Defects. In: Genetic Disorders and the Fetus: Diagnosis, Prevention and Treatment (6th edn), Milunsky A, Milunsky JM (eds). Johns Hopkins University Press: Baltimore. 2010;771-18.
7. Akolekar R, Syngelaki A, Sarquis R, et al. In Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11-13 weeks. Prenat Diagn 2011;31(1):66-74. Erratum 31:832.
8. Beta J, Bredaki FE, Rodriguez Calvo J, et al. Maternal serum α-fetoprotein at 11-13 weeks' gestation in spontaneous early preterm delivery. Fetal Diagn Ther 2011;30(2):88-93.
9. Royston P, Thompson SG. Model-based screening by risk with application to Down's syndrome. Stats in Med. 1992;11:257-68.
10. Cuckle H, Aitken D, Goodburn S, et al. Age-standardisation for monitoring performance in Down's syndrome screening programmes. Prenat Diagn 2004;24(11):851-6.
11. Cuckle HS, Wald NJ, Thompson SG. Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein level. Brit J Obstet Gynaecol 1987;94:387-402.
12. Spencer K, Liao AW, Ong CY, et al. First tirmester maternal serum placenta growth factor (PlGF) concentrations in pregnancies with fetal trisomy 21 or trisomy 18. Prenat Diagn 2001;21:718-22.
13. Cowans NJ, Alfthan H, Stenman UH, Spencer K. Stability of first trimester placental growth factor in serum and whole blood. Prenat Diagn 2011;31(12):1193-7.
14. Spencer K, Crossley JA, Aitken DA, et al. Temporal changes in maternal serum biochemical markers of trisomy 21 across the first and second trimester of pregnancy. Ann Clin Biochem 2002;39:567-76
15. Wald NJ, Rodeck C, Hackshaw AK, et al. First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS). Health Technol Assess 2003;7(11):1-88.
16. Wald NJ, George L, Smith D, et al. On behalf of the International Prenatal Screening Research Group. Serum screening for Down's syndrome between 8 and 14 weeks of pregnancy. Brit J Obstet Gynaecol 1996;l03:407-12.